Detection of clinically significant prostate cancer using magnetic resonance imaging–ultrasound fusion targeted biopsy: a systematic review M Valerio, I Donaldson, M Emberton, B Ehdaie, BA Hadaschik, LS Marks, ... European urology 68 (1), 8-19, 2015 | 555 | 2015 |
Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology clinical practice guideline endorsement RC Chen, RB Rumble, DA Loblaw, A Finelli, B Ehdaie, MR Cooperberg, ... Journal of Clinical Oncology 34 (18), 2182-2190, 2016 | 435 | 2016 |
Updated prostate imaging reporting and data system (PIRADS v2) recommendations for the detection of clinically significant prostate cancer using multiparametric MRI: critical … HA Vargas, AM Hötker, DA Goldman, CS Moskowitz, T Gondo, ... European radiology 26, 1606-1612, 2016 | 401 | 2016 |
Focal therapy: patients, interventions, and outcomes—a report from a consensus meeting IA Donaldson, R Alonzi, D Barratt, E Barret, V Berge, S Bott, D Bottomley, ... European urology 67 (4), 771-777, 2015 | 284 | 2015 |
An update of the American Urological Association white paper on the prevention and treatment of the more common complications related to prostate biopsy MA Liss, B Ehdaie, S Loeb, MV Meng, JD Raman, V Spears, SP Stroup The Journal of urology 198 (2), 329-334, 2017 | 267 | 2017 |
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinoma EK Cha, SF Shariat, M Kormaksson, G Novara, TF Chromecki, DS Scherr, ... European urology 61 (4), 818-825, 2012 | 228 | 2012 |
Active surveillance for prostate cancer: a narrative review of clinical guidelines SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ... Nature Reviews Urology 13 (3), 151-167, 2016 | 195 | 2016 |
The impact of repeat biopsies on infectious complications in men with prostate cancer on active surveillance B Ehdaie, E Vertosick, M Spaliviero, A Giallo-Uvino, Y Taur, M O'Sullivan, ... The Journal of urology 191 (3), 660-664, 2014 | 164 | 2014 |
Impact of smoking on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomy M Rink, E Xylinas, V Margulis, EK Cha, B Ehdaie, JD Raman, FK Chun, ... European urology 63 (6), 1082-1090, 2013 | 145 | 2013 |
Lymph node–positive bladder cancer treated with radical cystectomy and lymphadenectomy: effect of the level of node positivity TV Tarin, NE Power, B Ehdaie, JP Sfakianos, JL Silberstein, CJ Savage, ... European urology 61 (5), 1025-1030, 2012 | 142 | 2012 |
Limited versus extended pelvic lymph node dissection for prostate cancer: a randomized clinical trial KA Touijer, DD Sjoberg, N Benfante, VP Laudone, B Ehdaie, JA Eastham, ... European urology oncology 4 (4), 532-539, 2021 | 140 | 2021 |
Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy M Rink, EC Zabor, H Furberg, E Xylinas, B Ehdaie, G Novara, M Babjuk, ... European urology 64 (3), 456-464, 2013 | 130 | 2013 |
Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery M Rink, B Ehdaie, EK Cha, DA Green, PI Karakiewicz, M Babjuk, ... European urology 62 (4), 677-684, 2012 | 104 | 2012 |
Long-term outcomes of active surveillance for prostate cancer: the Memorial Sloan Kettering Cancer Center experience S Carlsson, N Benfante, R Alvim, DD Sjoberg, A Vickers, VE Reuter, ... The Journal of urology 203 (6), 1122-1127, 2020 | 103 | 2020 |
Androgen deprivation and thromboembolic events in men with prostate cancer B Ehdaie, CL Atoria, A Gupta, A Feifer, WT Lowrance, MJ Morris, ... Cancer 118 (13), 3397-3406, 2012 | 96 | 2012 |
Maintenance bacillus Calmette-Guérin treatment of non–muscle-invasive bladder cancer: A critical evaluation of the evidence B Ehdaie, R Sylvester, HW Herr European urology 64 (4), 579-585, 2013 | 89 | 2013 |
Obesity is associated with worse oncological outcomes in patients treated with radical cystectomy TF Chromecki, EK Cha, H Fajkovic, M Rink, B Ehdaie, RS Svatek, ... BJU international 111 (2), 249-255, 2013 | 88 | 2013 |
Reasons for discontinuing active surveillance: assessment of 21 centres in 12 countries in the Movember GAP3 Consortium M Van Hemelrijck, X Ji, J Helleman, MJ Roobol, W van der Linden, ... European urology 75 (3), 523-531, 2019 | 86 | 2019 |
Comparative outcomes of pure squamous cell carcinoma and urothelial carcinoma with squamous differentiation in patients treated with radical cystectomy B Ehdaie, A Maschino, SF Shariat, J Rioja, RJ Hamilton, WT Lowrance, ... The Journal of urology 187 (1), 74-79, 2012 | 86 | 2012 |
Role of changes in magnetic resonance imaging or clinical stage in evaluation of disease progression for men with prostate cancer on active surveillance GT Chesnut, EA Vertosick, N Benfante, DD Sjoberg, J Fainberg, T Lee, ... European urology 77 (4), 501-507, 2020 | 85 | 2020 |